Clinical Trial Update: Effect of Ticagrelor on Endothelial Function [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ticagrelor's effect on endothelial function in patients with coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Coronary Artery Disease, Endothelial Function | Phase 3 | Status: COMPLETED